Scynexis.

PositionRegional Report: Triangle

RESEARCH TRIANGLE PARK -- Scynexis has raised $29 million in venture capital. Among the drug company's investors were Alta Partners and Burrill & Co., both in San Francisco. Scynexis also announced that it will collaborate with New...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT